Jochen Springer

Title: Jochen Springer: Innovator in Beta Blocker Compositions

Introduction

Jochen Springer is a notable inventor based in Falkensee, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta blocker compositions. With a total of nine patents to his name, his work focuses on innovative treatments for serious medical conditions.

Latest Patents

One of Jochen Springer's latest patents involves S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis (ALS). This invention relates to the use of these beta blocker compositions not only for treating ALS but also for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life, and prolonging survival in ALS patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.

Career Highlights

Throughout his career, Jochen Springer has worked with various organizations, including Actimed Therapeutics Limited and Charité – Universitätsmedizin Berlin. His experience in these institutions has allowed him to advance his research and contribute to the development of effective medical treatments.

Collaborations

Jochen has collaborated with esteemed colleagues such as Stefan Anker and Andrew J S Coats. These partnerships have further enriched his research and innovation in the field of pharmaceuticals.

Conclusion

Jochen Springer is a distinguished inventor whose work in beta blocker compositions has the potential to significantly impact the treatment of amyotrophic lateral sclerosis and improve patient outcomes. His contributions to the field are noteworthy and continue to inspire advancements in medical science.